Table 3 Demographic and clinical characteristics of the study population – patients with success vs. failure of misoprostol treatment

Age

32.2 ± 6.2

34.11 ± 6.6

0.036

Gravidity

3.5 ± 2.5

4.4 ± 3.3

0.026

Parity

1.8 ± 1.9

2.6 ± 2.9

0.009

Number of past CS

0.32 ± 0.82

0.31 ± 0.66

0.98

Past miscarriages

0.71 ± 1.2

0.78 ± 1.2

0.67

Past misoprostol courses

0.09 ± 0.3

0.12 ± 0.57

0.61

Past D&C

0.25 ± 0.65

0.32 ± 0.74

0.53

Uterine position

0.28

 Anteverted

103/139 (74.1)

29/35 (82.9)

 Retroverted

36/139 (25.9)

6/35 (17.1)

Week of gestation

9.4 ± 1.8

9.4 ± 2.5

0.92

Week of gestation by US

6.8 ± 1.5

6.8 ± 1.2

0.81

Diagnosis

0.10

 Missed abortion

174 (84.1)

59 (92.2)

 Blighted ovum

33 (15.9)

5 (7.8)

Presence of gestational sac

200/203 (98.5)

61/61 (100)

0.34

Presence of yolk sac

89/183 (48.6)

34 /57 (59.7)

0.15

Presence of embryo

139/201 (69.2)

45/61 (73.8)

0.49

Presence of embryonic pulse prior to diagnosis of EPF

21/203 (10.3)

5/61 (8.2)

0.62

Gestational sac size length-mm

23.5 ± 11.7

33 ± 3.2

< 0.001

Embryo size according to CRL

8.9 ± 7.9

9.5 ± 10.1

0.72

Uterine size (weeks)

7.3 ± 1.3

7.2 ± 1.4

0.76

Bleeding at diagnosis

65 (31.4)

17 (26.6)

0.50